PharmaMar announces data presentations: Yondelis® and lurbinectedin at

(Pharmamar) During the Congress of the American Society of Clinical Oncology (ASCO) that will be held form the June 1-5 in Chicago (USA), PharmaMar will present the data obtained from various clinical studies of the molecules Yondelis ®, lurbinectedin (PM1183) and plitidepsin.

PharmaMar announces data presentations: Yondelis® and lurbinectedin at ASCO

Related Posts

Agriculture accelerated human genome evolution to capture energy from starchy foods

Samples from bottled water, tap water and household-treated tap water in San Francisco Bay Area indicate that all sources may have potential health risks, largely from trihalomethanes

Both cats and dogs often enjoy playing fetch with their owners

PCORI offers up to $100 million for new research promoting healthy children and youth

POPULAR NEWS

NYU Abu Dhabi researchers identify unique survival strategies adopted by fish in the world’s warmest waters

Scientists discover that a protein associated with neurodegenerative diseases is also linked to childhood brain cancer

UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?

CHOP experts describe types of rashes associated with MIS-C

About

Follow us

Recent News

A new, updated account of poroid fungi in North America

Few anti-immigration users dominate most of UK-based anti-immigration content on Twitter with rapid spread and high polarization

Agriculture accelerated human genome evolution to capture energy from starchy foods

Welcome Back!

Retrieve your password